Content about Chronic bronchitis

May 21, 2012
Screening for COPD

DSN recently talked with COPD Foundation founder and president John Walsh about the organization's new leadership. In March, the COPD Foundation took over leadership for Drive4COPD, which aims to screen people for chronic obstructive pulmonary disease, a collective term for emphysema and chronic bronchitis, which the group estimates to affect 24 million Americans who may have it but don't know it.

May 10, 2013
FDA approves Breo Ellipta for COPD

The Food and Drug Administration has approved a new treatment for chronic obstructive pulmonary disease, the agency said Friday.

January 30, 2013
FDA panel recommends approval for Boehringer Ingelheim COPD drug

A panel of Food and Drug Administration experts has recommended approval for an experimental drug made by Boehringer Ingelheim for chronic obstructive pulmonary disease, the drug maker said.

May 23, 2012
COPD spurs drug development

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention. And combined, the two diseases cause more than 100,000 deaths per year. Fortunately, however, there is a wide range of treatments available for both, many of which work for both diseases.

March 20, 2012
Novartis launches Arcapta Neohaler

Novartis has launched a new treatment for chronic obstructive pulmonary disease, the drug maker said Monday.

February 2, 2012
PhRMA: More than 50 drugs in development for COPD

More than 50 drugs are under development for treating a respiratory disease that is the third-leading cause of death in the United States.

July 5, 2011
Novartis receives FDA approval for COPD drug

The Food and Drug Administration has approved a drug made by Novartis for treating chronic obstructive pulmonary disease, the FDA said Friday.

June 10, 2011
Forest announces availability of Daliresp

A drug for chronic obstructive pulmonary disease made by Forest Labs will be available by the middle of this month, Forest said Thursday.

March 24, 2011
FDA extends NDA review for Novartis' COPD treatment

The Food and Drug Administration has extended its regulatory review period for Novartis' new drug application for its once-daily, long-term maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, as well as chronic bronchitis and/or emphysema, the drug maker said.

March 1, 2011
Forest gets nod for COPD drug

The Food and Drug Administration has approved a treatment for chronic obstructive pulmonary disease made by Forest Labs, the agency said Tuesday.

February 2, 2011
Drive4COPD achieves record

A coalition of companies, celebrities and health organizations has achieved its goal of screening 1 million Americans for risk of chronic obstructive pulmonary disease.

December 10, 2010
COPD now No. 3 leading cause of death among Americans

Chronic obstructive pulmonary disease is the third-leading cause of death in the United States, according to a new report by the Centers for Disease Control and Prevention.

© 2013 Drug Store News. All Rights Reserved.